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ALEXANDER TURCHIN, MD, MS
APOORVA TRIVEDI, BS
OBJECTIVEdHypoglycemia is associated with increased mortality in hospitalized patients.
We investigated the relationship between spontaneous hypoglycemia versus insulin-associated
hypoglycemia and mortality in hospitalized patients.
RESEARCH DESIGN AND METHODSdData for this retrospective cohort study were
obtained from electronicdatabases of patientsadmittedbetween 1 April2008 and 30 November
2010. Patients with one or more blood glucose values #50 mg/dL on point-of-care glucose
testing were considered hypoglycemic. Patients treated with insulin were assumed to have
insulin-associated hypoglycemia. Age-, sex-, and race-matched patients with all blood glucose
values .70 mg/dL were selectedas controls. The Charlson comorbidity index (CCI) wasused to
control for severity of illness.
RESULTSdT h e r ew e r ef o u rg r o u p s :1) noninsulin-treated hypoglycemia (NTH) (n =1 3 5 ) ,2)
insulin-treated hypoglycemia (ITH) (n = 961), 3) noninsulin-treated control (NTC) (n =1 , 0 5 8 ) ,
and 4) insulin-treated control (ITC) (n = 736). Mortality was higher in the ITH group compared
with the ITC group (20.3 vs. 4.5%, P , 0.0001), with a relatively higher CCI (1.8 vs. 1.5%, P ,
0.0001), but much higher in the NTHgroup compared with the NTC group (34.5 vs.1.1%, P ,
0.0001), with much higher CCI (2.4 vs. 1.1%, P , 0.0001). Mortality was higher in the NTH
group compared with the ITH group (P , 0.0001) but lower in the NTC group compared with
the ITC group (P , 0.0001). After controlling for age, sex, CCI, and admission to the intensive
care unit, insulin treatment was associated with a lower mortality among the hypoglycemic
patients; hazard ratio of death in the ITH group relative to the NTH group was 0.34 (95% CI
0.25–0.47, P , 0.0001).
CONCLUSIONSdInsulin-associated and spontaneous hypoglycemia are associated with
increased mortality among hospitalized patients.
Diabetes Care 36:1107–1110, 2013
H
ypoglycemia among hospitalized
patients is a common problem. In
previous studies, 7–10% of the pa-
tients admitted to the hospital were re-
ported to have at least one episode of
hypoglycemia (1,2). Most of these hypo-
glycemicepisodesweretreatmentrelated,
but spontaneous hypoglycemia is also
known to be frequent (1). Hypoglycemia
isassociatedwithincreasedmortality(2–6).
However, a cause and effect relationship
between hypoglycemia and mortality has
not been established (5). Patients with
more severe illnesses are more likely to
develop hypoglycemia irrespective of
insulin treatment and have a higher risk
of mortality (3,5). However, insulin-
inducedhypoglycemiamayhavedifferent
consequencesthanspontaneoushypogly-
cemia. A study of patients with acute
myocardial infarction suggested that iat-
rogenic hypoglycemia is associated with
lower mortality than spontaneous hypo-
glycemia (7). Another study of patients
admitted to the general wards showed
that drug-induced hypoglycemia was
not associated with increased mortality
and the association between spontaneous
hypoglycemia and mortality disappeared
after adjustment for comorbidities (1).
We investigated the association between
spontaneous hypoglycemia versus insulin-
associated hypoglycemia and mortality
among all hospitalized patients.
RESEARCH DESIGN AND
METHODSdData for this retrospec-
tive cohort study were obtained from the
Research Patient Database Registry
(RPDR) and point-of-care glucose meter
download data for patients admitted to
the Brigham and Women’sH o s p i t a lb e -
tween 1 April 2008 and 30 November
2010. The RPDR is a data warehouse
that serves as a central clinical data repos-
itory for participating hospitals and clin-
ics within the Partners HealthCare
system, an integrated health care delivery
network in eastern Massachusetts that in-
cludes Massachusetts General Hospital
and Brigham and Women’sH o s p i t a l .
Partners Healthcare Human Research
Committee approved the protocol and
waived the requirement for written in-
formed consent.
Hypoglycemic group
Hospitalized patients with one or more
blood glucose values #50 mg/dL on
point-of-care blood glucose testing were
included in this study. The exact date and
time of hypoglycemia were extracted
from the point-of-care glucose meter
download data.
Detailed demographic data and hos-
pitalization records that included all di-
agnoses, some laboratory reports, and
prescribed medications were obtained
fromtheRPDR.Thedateofhypoglycemia
was matched to the hospitalization pe-
riod. If multiple hospitalizations were
present for a particular patient, the last
hospitalization was used in the analysis.
If a patient had suffered more than one
hypoglycemic episode during hospitali-
zation, the ﬁrst episode of hypoglycemia
was considered the key event. When
insulin was used during hospitalization,
hypoglycemia was assumed to be insulin
related. When no insulin was used, hy-
poglycemia was assumed to be of spon-
taneous origin. Patients receiving oral
antidiabetic agents during hospitalization
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ORIGINAL ARTICLEwereexcluded.Mortalitydataduringhos-
pitalization were obtained, and the time
period between hypoglycemia and death
was noted.
Control group
A control group of patients admitted dur-
ing the same time period (1 April 2008 to
30November2010)withnobloodglucose
value ,70 mg/dL on point-of-care blood
glucose testing was selected. For each sex/
race/age decade characteristic combination
amonghypoglycemicpatients,weobtained
matched controls with the same character-
isticcombination,aimingforthenumberof
controlstobetwicethenumberofcasesfor
each characteristic combination. The re-
sulting number of controls was less than
twicethenumberofhypoglycemicpatients
due to limited availability. If there were
multiple hospitalizations for a control pa-
tient, the last hospitalization was used in
the analysis. Insulin usage and death dur-
ing hospitalization were noted.
Statistical analysis
The primary outcome was death during
the hospital stay. Data were summarized
asnumberswithpercentageormeansand
SD. The Charlson comorbidity index
(CCI) was calculated from the ICD-9
codes (8). Patient characteristics were
comparedbetweengroupsusingWilcoxon
rank sum test, x
2 test, or logistic regres-
sion for mortality. Groupswere compared
in terms of the time from hypoglycemia to
death during hospitalization or censoring
at discharge using the log-rank test and
Kaplan-Meier plot. Cox regression was
used to assess the signiﬁcance of single
and simultaneous multiple predictors of
death, with hazard ratios (HRs) and 95%
CIs, accounting for intracluster depen-
dence resulting from the method of
selecting the control group (9). Potential
confounders of group comparisons in-
cluded the CCI and admission to the in-
tensive care unit (ICU), insulin, age, sex,
andrace.Theretentionofcovariatesinthe
ﬁnal model depended on the association
with mortality (P , 0.10). Statistical anal-
yses were performed using SAS version
9.2 (Cary, NC).
RESULTSdA total of 2,890 patients
were included in this study and divided
into four groups: 1) noninsulin-treated
hypoglycemia (NTH) (n = 135), 2) insulin-
treated hypoglycemia (ITH) (n = 961), 3)
noninsulin-treated control (NTC) (n =
1,058), and 4) insulin-treated control
(ITC) (n = 736). Hypoglycemic patients
were more likely to have diabetes and re-
ceive insulin treatment. They were sicker,
as indicated by higher CCI and more ad-
missions to the ICU. Mortality among hy-
poglycemicpatientswasninetimeshigher
than mortality among control patients
(22.1 vs. 2.5%; P , 0.0001). Differences
between insulin-treated versus noninsu-
lin-treated groups are shown in Table 1.
Insulin-treated hypoglycemic patients as
well as the ITC patients were older and
morelikelytohaveadiagnosisofdiabetes.
Patients in the NTH group were sicker
with a higher CCI and more admissions
to the ICU as compared with the ITH
group, a relation that was reversed in the
controlgroup,withNTCpatientshavinga
lower CCI than ITC patients. Mortality
during hospitalization was higher in the
NTHgroupcomparedwiththeITHgroup
(P , 0.0001) but lower in the NTC group
compared with the ITC group (P ,
0.0001). Mortality was higher in the ITH
groupcomparedwiththeITCgroup(20.3
vs. 4.5%, P , 0.0001), with a relatively
small difference in the CCI (1.8 vs. 1.5%,
P,0.0001),butmuchhigherintheNTH
g r o u pc o m p a r e dw i t ht h eN T Cg r o u p
(34.5 vs. 1.1%, P , 0.0001), with much
higher CCI (2.4 vs. 1.1%, P , 0.0001).
Mortalityduringhospitalizationwashigh-
est in the NTH group followed by the ITH
and ITC groups.
On univariate regression analysis, the
CCI and admission to the ICU were
associated with higher mortality, whereas
female sex and insulin treatment were
associated with lower mortality (Table 2).
The HR for death in the ITH group rela-
tive to the NTH group in a multiple vari-
able model that included CCI, age, sex,
and admission to the ICU as covariates
was 0.34 (95% CI 0.25–0.47, P ,
0.0001) (Table 3). The Kaplan-Meier
plot depicts better survival after hypogly-
cemia in insulin-treated patients com-
pared with spontaneous hypoglycemic
patients, especially in the ﬁrst 2 weeks,
where mostof thedata wereconcentrated
(Fig. 1).
CONCLUSIONSdThis study shows
that hypoglycemia in hospitalized pa-
tients, whether insulin induced or sponta-
neous,isassociatedwithincreasedmortality
ascomparedwithabsenceofhypoglycemia.
As expected, insulin-treated patients in
our study were more likely to have dia-
betes and were older than the noninsulin-
treated patients. Higher mortality in the
ITC group compared with the NTC group
may be due to their older age and higher
prevalence ofdiabetes.However,thepres-
ence of hypoglycemia in insulin-treated
patients increased their risk of death
several-fold compared with ITC patients,
even though this risk was lower than that
in spontaneously hypoglycemic patients.
This ﬁnding is in contrast to the previous
studies that showed that insulin-induced
hypoglycemia (,70 mg/dL) was not asso-
ciated with increased risk of mortality
(1,7).Ourstudy isdifferent from previous
studies due to a different patient popula-
tion and inclusion of patients with more
severe hypoglycemia. Nonetheless, in our
study, insulin was highly associated with
longer survival and ICU admission was
Table 1dPatient characteristics and group comparisons








(n = 1,058) P
Presence of diabetes 41.3% 16.3% ,0.0001 51.2% 12.8% ,0.0001
CCI 1.8 6 2.2 2.4 6 2.5 ,0.0001 1.5 6 2.0 1.4 6 2.3 ,0.0001
Length of stay (days) 21.0 6 20.4 9.7 6 9.2 ,0.0001 7.5 6 7.4 4.7 6 5.2 ,0.0001
Admission to ICU 62.0% 51.1% 0.01 29.1% 10.1% ,0.0001
Mortality 20.3% 34.8% ,0.0001* 4.5% 1.1% 0.02*
*Adjusted for CCI, age, sex, and admission to ICU in multiple variable models.
Table 2dAnalysis of individual variables
predicting mortality after hypoglycemia
(n = 1,096)
P HR 95% CI
Insulin treatment ,0.0001 0.39 0.30–0.52
CCI 0.0084 1.07 1.02–1.12
Age 0.08 1.01 0.99–1.02
Female sex 0.03 0.78 0.61–0.98
White race 0.43 1.14 0.83–1.56
Admission to
ICU ,0.0001 3.93 2.42–6.36
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Hypoglycemia and mortality among hospitalized patientshighly associated with shorter survival in
patients with hypoglycemia.
Although early trials of tight glycemic
control in critically ill hospitalized pa-
tients showed beneﬁts of tight glycemic
control, subsequent trials either failed to
show beneﬁts or ended early due to the
risk of hypoglycemia (10–14). One of the
potential explanations for the failure of
tight glycemic control has been the high
risk of hypoglycemia. Current American
Diabetes Association guidelines recom-
mend avoiding hypoglycemia in hospital-
izedpatients (15).Hypoglycemicpatients
often have more severe illnesses. Most
studies, in the inpatient setting as well as
in the outpatient setting, have demon-
strated that spontaneous hypoglycemia is
associatedwithincreasedmortalityascom-
pared with insulin-induced hypoglycemia,
and our study supports these data
(7,16,17). However, our study also shows
that mortality in the ITH group was still
very high, suggesting only a partial, if any,
protective effect of insulin. We think insu-
linadministrationmayunmaskhypoglyce-
miamoreeasilyinsickerpatients.Whether
hypoglycemia causes increased mortality
remains unclear.
Our study has several limitations that
areexpected ofretrospectivestudies.This
was a single-center study, and the sample
size for the spontaneous hypoglycemia
group was rather small. We did not have
data on the nutritional status of the
patients. Also, we did not have details
about the type of diabetes, duration of
diabetes, insulin regimens, or glucose
control. We assumed that hypoglycemia
in insulin-treated patients was insulin
associated even though we did not have
information about the exact time of in-
sulin injection and the relation between
insulin injection and hypoglycemia. Fur-
thermore, our analyses did not include
adjustments for several confounders, in-
cluding serum creatinine, hematocrit, al-
bumin, and the use of other medications,
including steroids. However, we did con-
trol for comorbidity and the severity of
illness by including the CCI and admis-
s i o nt ot h eI C U .W et h i n kt h e s ed a t ap r o -
vide valuable information on the relation
between hypoglycemia and mortality in the
inpatient setting.
We conclude that insulin-induced
hypoglycemia as well as spontaneous hy-
poglycemia is associated with increased
mortality among hospitalized patients.
Prospective studies are needed to deter-
mine whether the prevention of hypogly-
cemia improves outcome in hospitalized
patients.
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